TENX — Tenax Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial
U.S. STOCKS ON THE MOVE-SpaceX, AAON, Vertex Pharma
U.S. STOCKS ON THE MOVE-Apple, Barrick Mining, AbCellera Biologics
Tenax Therapeutics falls after heart drug misses late-stage study goal
Tenax heart drug fails to improve walking results in study, shares plunge (updated)
Tenax Therapeutics' heart drug misses main goal in late-stage study
Tenax Therapeutics Q2 net loss widens on higher R&D costs
Brief: Tenax Therapeutics Q2 Net Income USD -17.803 Million
Brief: Tenax Therapeutics Extends Us Regulatory Approval Deadline To December 31, 2035 Via Sixth Amendment To Orion License - SEC Filing
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
Tenax Therapeutics Q1 net loss widens on higher R&D costs
Brief: Tenax Therapeutics Q1 Net Income USD -15.716 Million
Brief: Tenax Therapeutics announces inducement grants under Nasdaq listing rule 5635(C)(4)
Brief: Tenax Therapeutics May Offer Up To $300 Million Of Securities
Tenax Therapeutics Q4 net loss widens on higher R&D expenses
Brief: Tenax Therapeutics Q4 Net Income USD -15.54 Million
Brief: Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026